EP3236953

SITE SPECIFIC DOSING OF A BTK INHIBITOR

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    23.12.2015
  • EP published:
    11.11.2020
  • EP application number:
    15826209.7
  • Max expiry date:
    22.12.2035
  • Title:
    SITE SPECIFIC DOSING OF A BTK INHIBITOR

Timeline

Today
23.12.2015EP application
11.11.2020EP Publication

Owner

  • Name:
    Principia Biopharma Inc.
  • Address:
    220 E. Grand Ave., S. San Francisco, CA 94080, US

Inventor

  • Name:
    NUNN, Philipp
  • Address:
    Mountain View, CA 94014, US
  • Name:
    BERNER, Bret
  • Address:
    Seattle, WA 98116, US
  • Name:
    MASJEDIZADEH, Mohammad
  • Address:
    San Jose, CA 95124, US

Priority

  • Number:
    201462096809 P
  • Date:
    24.12.2014
  • Country:
    US

Classification

  • Categories:
    A61K 9/50, A61K 9/28, A61K 31/506, A61K 31/519, A61K 9/48

Upload documents